socalTECH
JANUARY 9, 2013
San Diego-based renewable energy developer EDF Renewable Energy gained a big new partner Wednesday: Google , after Google said it invested $200M in equity in a wind farm in West Texas. Google said that Spnning Spur joins 10 other renewable energy investments it has made since 2010.
socalTECH
JUNE 16, 2017
San Diego-based renewable energy developer EDF Renewable Energy announced early Friday moring that it has sold off 50 percent of the Great Western Wind Project, a 225 megawatt wind energy project it is developing in Oklahoma for Google. Financial details of that sale were not announced.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
APRIL 14, 2011
in San Diego. Although dollars were up, the number of deals (736 nationally in Q1 vs. 827 deals last year) was the lowest in a single quarter since Q3 of 2009. Locally, the report totaled $201.28M in deals in the Los Angeles area, $191.89M in the Orange County area, and $100.0M Associates , all with three deals each.
Xconomy
SEPTEMBER 18, 2018
New York-based UiPath is the latest such company to score a haul, announcing Tuesday it raised $225 million in a Series C funding round co-led by earlier investor CapitalG —the growth equity investment fund of Google parent company Alphabet—and Sequoia Capital, a new investor.
Xconomy
OCTOBER 26, 2018
San Diego startup Cuida Health, a recent graduate of the Connect Springboard accelerator program, this week launched its first product: a voice-activated “social wellness” app for seniors. Lisa doesn’t interrupt. She doesn’t mind long pauses between responses. And she has a sense of humor. Oh – and, she’s virtual.
socalTECH
NOVEMBER 14, 2019
San Diego-based Daasity (www.daasity.com) which just raised $2.3M Maybe they might be using a platform like Shopify to sell their products and power their website, and they might use Facebook for advertising, and maybe they're using paid search with Google. So, what are you working now and where are you going next?
Xconomy
APRIL 17, 2020
The public markets are moving erratically, but Alnylam Pharmaceuticals showed this week that selling equity isn’t the only way for biotech companies to raise cash. Late last year Alnylam (NASDAQ: ALNY ) began exploring potential royalty deals for inclisiran, a drug that uses RNA interference to lower cholesterol.
Expert insights. Personalized for you.
113 
Let's personalize your content